ArticleCureus2026
Global Research Trends in Gastric Cancer Epigenetics From 2005 to 2025.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastric cancer (GC) is one of the most common malignant tumors in the digestive tract, characterized by a high degree of malignancy and a poor prognosis. Complex disease heterogeneity, late diagnosis, and suboptimal treatment often lead to poor prognoses for patients. In addition to genetic alterations and environmental factors, changes in epigenetic mechanisms also play an important role in the occurrence and progression of GC. Revealing the current research status of epigenetics in GC has important guiding significance for the diagnosis and treatment of GC, as well as for future research directions. METHODOLOGY: In this study, we used specific keywords to search for publications related to gastric cancer epigenetics (GCE) published in the past 20 years in the Web of Science Core Collection database. The VOSviewer software (Version 1.6.20; Center for Science and Technology Studies (CWTS), Leiden University, Leiden, The Netherlands) was used to conduct clustering and co-occurrence analysis on countries, authors, institutions, and keywords in the publications. CiteSpace software (Version 6.3.1R6; Chaomei Chen, College of Computing and Informatics, Drexel University, Philadelphia, PA) was used for burst analysis and timeline clustering analysis.
resultA total of 4,655 papers on GC in the field of epigenetics were retrieved. China is the country with the largest number of published papers (
conclusionsBased on bibliometric methods, this study provides new insights into the research progress of GC from the perspective of epigenetics and offers new ideas and inspirations for future GC research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.